Evidence map›Paper›PMID 39623234›Full record

ArticleAesthetic plastic surgery2025

The Use of the Hemostatic Net in Asian Population: Hyperpigmentation and the Duration Required for Hemostatic Net Marking to Disappear.

Apinut Wongkietkachorn, Nuttapone Wongkietkachorn

Abstract read
In one paragraph

Article in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Apinut WongkietkachornPlastic and Reconstructive Surgery Unit, QPrime Surgical Center, Bangkok, Thailand. apinutme@gmail.com.ORCID 0000-0003-2075-1090
Nuttapone WongkietkachornPlastic and Reconstructive Surgery Unit, QPrime Surgical Center, Bangkok, Thailand.

Funding

Pheu Ter Foundation
6 · The paper itself

Abstract

introductionThere are major concerns about using the hemostatic net in Asian populations due to potential hyperpigmentation and the extended duration required for the markings to disappear. This study is the first to describe its use in this demographic and aims to determine the occurrence of hyperpigmentation from the hemostatic net and the time required for the markings to fade.

methodsA retrospective review was conducted in patients who had a hemostatic net applied during facial surgery between July 2022 and April 2024 at Qprime Surgical Center in Bangkok, Thailand. The hemostatic net was applied using 5-0 nonabsorbable materials with needle sizes of 16 mm or 19 mm.

resultsA total of 300 patients were included in this study. No persistent hyperpigmentation from the hemostatic net was observed. The disappearance rates of the hemostatic net markings were as follows: 33.3% at 2 weeks, 10.0% at 3 weeks, 46.7% at 4 weeks, 3.3% at 6 weeks, and 6.7% at 8 weeks. Overall, 90.0% of the hemostatic net markings subsided within 1 month.

conclusionThe use of the hemostatic net in the Asian population studied resulted in remarkable prevention of hematomas after facelifts and no persistent hyperpigmentation, with the majority of the markings disappearing within one month, thereby reinforcing the efficacy and safety of this technique. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors   www.springer.com/00266 .

Indexed as

Asian PeopleHemostatic TechniquesHyperpigmentationRhytidoplastyAdultFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesThailandTime FactorsTreatment OutcomeYoung AdultHematomaHemostaticsHumansHyperpigmentationRetrospective studies

Identifiers

PMID39623234
PMCPMC11870942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.